LakeShore Days Sales Outstanding from 2010 to 2024

LSBPW Stock   0.04  0  6.29%   
LakeShore Biopharma Days Sales Outstanding yearly trend continues to be fairly stable with very little volatility. Days Sales Outstanding is likely to outpace its year average in 2024. During the period from 2010 to 2024, LakeShore Biopharma Days Sales Outstanding regression line of quarterly data had mean square error of  1,162 and geometric mean of  325.87. View All Fundamentals
 
Days Sales Outstanding  
First Reported
2010-12-31
Previous Quarter
284.62897196
Current Value
304.39
Quarterly Volatility
43.52404939
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check LakeShore Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LakeShore Biopharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 37.9 M, Interest Expense of 29.6 M or Selling General Administrative of 130.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Ptb Ratio of 0.0 or Days Sales Outstanding of 304. LakeShore financial statements analysis is a perfect complement when working with LakeShore Biopharma Valuation or Volatility modules.
  
Check out the analysis of LakeShore Biopharma Correlation against competitors.

Latest LakeShore Biopharma's Days Sales Outstanding Growth Pattern

Below is the plot of the Days Sales Outstanding of LakeShore Biopharma Co, over the last few years. It is LakeShore Biopharma's Days Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LakeShore Biopharma's overall financial position and show how it may be relating to other accounts over time.
Days Sales Outstanding10 Years Trend
Slightly volatile
   Days Sales Outstanding   
       Timeline  

LakeShore Days Sales Outstanding Regression Statistics

Arithmetic Mean329.00
Geometric Mean325.87
Coefficient Of Variation13.23
Mean Deviation34.28
Median352.37
Standard Deviation43.52
Sample Variance1,894
Range128
R-Value(0.66)
Mean Square Error1,162
R-Squared0.43
Significance0.01
Slope(6.39)
Total Sum of Squares26,521

LakeShore Days Sales Outstanding History

2024 304.39
2023 284.63
2022 245.95
2021 223.92

About LakeShore Biopharma Financial Statements

LakeShore Biopharma investors use historical fundamental indicators, such as LakeShore Biopharma's Days Sales Outstanding, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in LakeShore Biopharma. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Sales Outstanding 284.63  304.39 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for LakeShore Stock Analysis

When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.